Cargando…
Nifedipine Potentiates Susceptibility of Salmonella Typhimurium to Different Classes of Antibiotics
The calcium channel blocker nifedipine induces cellular iron export, thereby limiting the availability of the essential nutrient iron for intracellular pathogens, resulting in bacteriostatic activity. To study if nifedipine may exert a synergistic anti-microbial activity when combined with antibioti...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8532624/ https://www.ncbi.nlm.nih.gov/pubmed/34680781 http://dx.doi.org/10.3390/antibiotics10101200 |
_version_ | 1784587110935691264 |
---|---|
author | Haschka, David Grander, Manuel Eibensteiner, Johannes Dichtl, Stefanie Koppelstätter, Sabine Weiss, Günter |
author_facet | Haschka, David Grander, Manuel Eibensteiner, Johannes Dichtl, Stefanie Koppelstätter, Sabine Weiss, Günter |
author_sort | Haschka, David |
collection | PubMed |
description | The calcium channel blocker nifedipine induces cellular iron export, thereby limiting the availability of the essential nutrient iron for intracellular pathogens, resulting in bacteriostatic activity. To study if nifedipine may exert a synergistic anti-microbial activity when combined with antibiotics, we used the mouse macrophage cell line RAW267.4, infected with the intracellular bacterium Salmonella Typhimurium, and exposed the cells to varying concentrations of nifedipine and/or ampicillin, azithromycin and ceftriaxone. We observed a significant additive effect of nifedipine in combination with various antibiotics, which was not observed when using Salmonella, with defects in iron uptake. Of interest, increasing intracellular iron levels increased the bacterial resistance to treatment with antibiotics or nifedipine or their combination. We further showed that nifedipine increases the expression of the siderophore-binding peptide lipocalin-2 and promotes iron storage within ferritin, where the metal is less accessible for bacteria. Our data provide evidence for an additive effect of nifedipine with conventional antibiotics against Salmonella, which is partly linked to reduced bacterial access to iron. |
format | Online Article Text |
id | pubmed-8532624 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-85326242021-10-23 Nifedipine Potentiates Susceptibility of Salmonella Typhimurium to Different Classes of Antibiotics Haschka, David Grander, Manuel Eibensteiner, Johannes Dichtl, Stefanie Koppelstätter, Sabine Weiss, Günter Antibiotics (Basel) Article The calcium channel blocker nifedipine induces cellular iron export, thereby limiting the availability of the essential nutrient iron for intracellular pathogens, resulting in bacteriostatic activity. To study if nifedipine may exert a synergistic anti-microbial activity when combined with antibiotics, we used the mouse macrophage cell line RAW267.4, infected with the intracellular bacterium Salmonella Typhimurium, and exposed the cells to varying concentrations of nifedipine and/or ampicillin, azithromycin and ceftriaxone. We observed a significant additive effect of nifedipine in combination with various antibiotics, which was not observed when using Salmonella, with defects in iron uptake. Of interest, increasing intracellular iron levels increased the bacterial resistance to treatment with antibiotics or nifedipine or their combination. We further showed that nifedipine increases the expression of the siderophore-binding peptide lipocalin-2 and promotes iron storage within ferritin, where the metal is less accessible for bacteria. Our data provide evidence for an additive effect of nifedipine with conventional antibiotics against Salmonella, which is partly linked to reduced bacterial access to iron. MDPI 2021-10-01 /pmc/articles/PMC8532624/ /pubmed/34680781 http://dx.doi.org/10.3390/antibiotics10101200 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Haschka, David Grander, Manuel Eibensteiner, Johannes Dichtl, Stefanie Koppelstätter, Sabine Weiss, Günter Nifedipine Potentiates Susceptibility of Salmonella Typhimurium to Different Classes of Antibiotics |
title | Nifedipine Potentiates Susceptibility of Salmonella Typhimurium to Different Classes of Antibiotics |
title_full | Nifedipine Potentiates Susceptibility of Salmonella Typhimurium to Different Classes of Antibiotics |
title_fullStr | Nifedipine Potentiates Susceptibility of Salmonella Typhimurium to Different Classes of Antibiotics |
title_full_unstemmed | Nifedipine Potentiates Susceptibility of Salmonella Typhimurium to Different Classes of Antibiotics |
title_short | Nifedipine Potentiates Susceptibility of Salmonella Typhimurium to Different Classes of Antibiotics |
title_sort | nifedipine potentiates susceptibility of salmonella typhimurium to different classes of antibiotics |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8532624/ https://www.ncbi.nlm.nih.gov/pubmed/34680781 http://dx.doi.org/10.3390/antibiotics10101200 |
work_keys_str_mv | AT haschkadavid nifedipinepotentiatessusceptibilityofsalmonellatyphimuriumtodifferentclassesofantibiotics AT grandermanuel nifedipinepotentiatessusceptibilityofsalmonellatyphimuriumtodifferentclassesofantibiotics AT eibensteinerjohannes nifedipinepotentiatessusceptibilityofsalmonellatyphimuriumtodifferentclassesofantibiotics AT dichtlstefanie nifedipinepotentiatessusceptibilityofsalmonellatyphimuriumtodifferentclassesofantibiotics AT koppelstattersabine nifedipinepotentiatessusceptibilityofsalmonellatyphimuriumtodifferentclassesofantibiotics AT weissgunter nifedipinepotentiatessusceptibilityofsalmonellatyphimuriumtodifferentclassesofantibiotics |